Financial statements Exim Pharma
Balance sheet of Exim Pharma
Company age:
Age:
10 y. 1 m. 14 d.
Share capital:
Share capital:
5 000 PLN
Balance sheet data of EXIM PHARMA
|
Year
|
2018
|
2019
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 1 202 188,60 | 2 490 362,39 | 13 056 135,86 | 28 430 233,11 | 43 157 930,11 |
| A. Fixed assets | 320 129,68 | 446 882,50 | 5 219 786,26 | 11 926 688,39 | 19 587 290,09 |
| B. Current assets | 882 058,92 | 2 043 479,89 | 7 836 349,60 | 16 503 544,72 | 23 570 640,02 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 202 188,60 | 2 490 362,39 | 13 056 135,86 | 28 430 233,11 | 43 157 930,11 |
| A. Equity | 708 806,44 | 1 401 117,10 | 6 524 276,10 | 9 441 340,46 | 32 183 046,42 |
| B. Liabilities and provisions for liabilities | 493 382,16 | 1 089 245,29 | 6 531 859,76 | 18 988 892,65 | 10 974 883,69 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 862 308,16 |
| II. Short-term liabilities | 493 382,16 | 1 089 245,29 | 6 531 859,76 | 18 796 091,29 | 9 561 823,16 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.